ALOX5 and graft versus host disease: Inhibiting 5-lipoxygenase (5-LO), an FAO-enzyme producing the proinflammatory leukotriene B4, by zileuton (clinically used for asthma treatment) or by transplantation of 5-LO-deficient leukocytes, improved survival and alleviated GvHD (16).